• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C3在肾病患者肾脏近端小管刷状缘的体内定位。

In vivo localization of C3 on the brush border of proximal tubules of kidneys from nephrotic patients.

作者信息

Camussi G, Stratta P, Mazzucco G, Gaido M, Tetta C, Castello R, Rotunno M, Vercellone A

出版信息

Clin Nephrol. 1985 Mar;23(3):134-41.

PMID:3886230
Abstract

Deposits of C3 but not of C1q and C4 were detected on the proximal tubules of kidneys from nephrotic patients with non-selective proteinuria. The incidence of tubular C3 deposits was significantly higher in patients with membranous glomerulonephritis, focal glomerulosclerosis, membrano-proliferative glomerulonephritis and non-selective proteinuria than in patients with minimal change disease, nephrotic syndrome and selective proteinuria or in patients with glomerular disease, but without nephrotic syndrome. The occurrence of tubular C3 deposits was positively correlated with the amount of urinary C3 excretion. In vitro studies showed that the human normal kidney as well as pathologic specimens negative for in vivo tubular C3 deposits were able to bind C3 on the brush border of proximal tubules when incubated with fresh heterologous serum. In contrast, in patients with non-selective proteinuria and in vivo tubular C3 deposits, the binding of heterologous C3 to the brush border of proximal tubules was markedly reduced. The positive correlation between the occurrence of tubular C3 deposits and the urinary complement excretion, together with the detection of the C3 breakdown products in the urines further supported the hypothesis that complement components, once filtrated through the glomerular barrier, might be activated by the brush border of the proximal tubule.

摘要

在非选择性蛋白尿的肾病患者的肾脏近端小管中检测到C3沉积,但未检测到C1q和C4沉积。膜性肾小球肾炎、局灶性肾小球硬化、膜增生性肾小球肾炎和非选择性蛋白尿患者的肾小管C3沉积发生率显著高于微小病变病、肾病综合征和选择性蛋白尿患者或无肾病综合征的肾小球疾病患者。肾小管C3沉积的发生与尿C3排泄量呈正相关。体外研究表明,人正常肾脏以及体内肾小管C3沉积阴性的病理标本在与新鲜异源血清孵育时能够在近端小管刷状缘结合C3。相反,在非选择性蛋白尿和体内有肾小管C3沉积的患者中,异源C3与近端小管刷状缘的结合明显减少。肾小管C3沉积的发生与尿补体排泄之间的正相关,以及尿中C3裂解产物的检测进一步支持了这样的假设,即补体成分一旦通过肾小球屏障滤过,可能会被近端小管的刷状缘激活。

相似文献

1
In vivo localization of C3 on the brush border of proximal tubules of kidneys from nephrotic patients.C3在肾病患者肾脏近端小管刷状缘的体内定位。
Clin Nephrol. 1985 Mar;23(3):134-41.
2
Immunohistologic features of minimal-change nephrotic syndrome.微小病变型肾病综合征的免疫组织学特征。
Arch Pathol Lab Med. 1977 Jul;101(7):345-9.
3
Complement activation by tubular cells is mediated by properdin binding.肾小管细胞的补体激活由备解素结合介导。
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1397-403. doi: 10.1152/ajprenal.90313.2008. Epub 2008 Aug 27.
4
[Plasma level of complement fractions C3 and C4 in children with glomerular nephropathies. Correlations with morphological and immunopathological studies of renal biopsies].[肾小球肾病患儿血浆补体C3和C4水平。与肾活检形态学及免疫病理学研究的相关性]
Arch Fr Pediatr. 1976 Nov;33(G):853-72.
5
Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).慢性膜增生性肾小球肾炎(CMPGN)中补体成分、C3前活化剂及其他血清蛋白的清除率
Clin Nephrol. 1975;3(4):139-47.
6
Evolution of membranous nephropathy from a proliferative and exudative glomerulonephritis--a report of three cases studied by serial biopsies.膜性肾病由增生性和渗出性肾小球肾炎演变而来——三例经系列活检研究的报告
Int J Pediatr Nephrol. 1985 Apr-Jun;6(2):105-10.
7
Study of the correlation between glomerular and urinary sediment deposits using immunofluorescent technique.
Biomedicine. 1977 Mar;27(2):89-92.
8
Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.严重的肾小球上皮细胞损伤并不能阻止大鼠被动型海曼肾炎的发生。
Clin Exp Immunol. 1983 Jan;51(1):38-44.
9
Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.致密沉积物病良性亚型的特征:与该疾病进展型的比较。
Clin Nephrol. 1983 Oct;20(4):163-71.
10
Antibody-mediated proliferation of proximal tubule cells.抗体介导的近端肾小管细胞增殖。
Clin Exp Immunol. 1988 Jan;71(1):107-12.

引用本文的文献

1
Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases.顶端肾小管补体激活与蛋白尿性肾脏疾病中的肾功能丧失
Clin Kidney J. 2024 Jul 10;17(8):sfae215. doi: 10.1093/ckj/sfae215. eCollection 2024 Aug.
2
Alternative pathway diagnostics.替代途径诊断。
Immunol Rev. 2023 Jan;313(1):225-238. doi: 10.1111/imr.13156. Epub 2022 Oct 28.
3
Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
补体因子 H 相关蛋白 5 对肾近端小管上皮细胞的影响及其机制研究
Front Immunol. 2020 Aug 7;11:1643. doi: 10.3389/fimmu.2020.01643. eCollection 2020.
4
CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation.使用 CRISPR/Cas9 编辑 hTERT 永生化人细胞敲除 CD46 可调节补体激活。
PLoS One. 2019 Apr 8;14(4):e0214514. doi: 10.1371/journal.pone.0214514. eCollection 2019.
5
C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis.C3a 和 suPAR 驱动局灶节段性肾小球硬化症中肾小管细胞的 versican V1 表达。
JCI Insight. 2019 Apr 4;4(7). doi: 10.1172/jci.insight.122912.
6
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.尿补体蛋白与 2 型糖尿病患者肾脏疾病进展和死亡风险
Diabetes Care. 2018 Nov;41(11):2361-2369. doi: 10.2337/dc18-0699. Epub 2018 Aug 27.
7
Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.高血压患者的免疫系统失调会导致慢性 RAS 抑制的白蛋白尿的发生。
Sci Rep. 2017 Aug 21;7(1):8894. doi: 10.1038/s41598-017-09042-2.
8
Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.糖尿病肾病中的免疫与炎症:将机制转化为生物标志物和治疗靶点。
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F716-F731. doi: 10.1152/ajprenal.00314.2016. Epub 2016 Aug 24.
9
Complement activation in progressive renal disease.进行性肾脏疾病中的补体激活。
World J Nephrol. 2015 Feb 6;4(1):31-40. doi: 10.5527/wjn.v4.i1.31.
10
Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease.鉴定管状肝素硫酸盐作为蛋白尿性肾脏疾病中替代补体成分备解素的 docking 平台。
J Biol Chem. 2011 Feb 18;286(7):5359-67. doi: 10.1074/jbc.M110.167825. Epub 2010 Dec 6.